You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
  1. CORPORATE - 12-11-2014

    Kedrion joins the programme “ELITE for Large Corporates”

    Launched by Borsa Italiana, ELITE is targeted to companies aiming at strengthening their global leadership

    read more 
  2. CORPORATE - 17-10-2014

    Kedrion announces more factual, long-term role in Africa

    The company’s efforts try to grant African patients better access to treatments

    read more 
  3. CORPORATE - 20-05-2014

    Kedrion, one of Italy’s most innovative companies in 2014

    The MIT Technology Review Italia’s award given in Bologna in mid-May

    read more 
  4. CORPORATE - 17-04-2014

    5-year unrated EUR 300 million bond successfully launched

    The bonds have been placed with leading international institutional investors and will be listed on the Irish Stock Exchange

    read more 

Pages

For more information please contact: pressoffice@kedrion.com